Chiba, Japan

Hiroyuki Ishiwata


 


Average Co-Inventor Count = 6.5

ph-index = 4

Forward Citations = 41(Granted Patents)


Location History:

  • Ichikawa, JP (1993 - 2007)
  • Chiba, JP (2008 - 2012)
  • Tokyo, JP (2013 - 2014)
  • Higashimurayama, JP (1988 - 2015)

Company Filing History:


Years Active: 1988-2015

Loading Chart...
Loading Chart...
Loading Chart...
22 patents (USPTO):Explore Patents

Title: Hiroyuki Ishiwata: An Innovator in Pharmaceutical Patents

Introduction

Hiroyuki Ishiwata is a prominent inventor based in Chiba, Japan, who has made significant contributions to the field of pharmaceuticals. With a notable portfolio consisting of 22 patents, Ishiwata has focused his research on compounds that enhance the production of vital biological elements, such as erythropoietin and hemoglobin.

Latest Patents

Ishiwata’s latest patents include innovative compounds aimed at addressing critical health issues. One such invention is a prophylactic and/or therapeutic agent for anemia, incorporating a tetrahydroquinoline compound as an active ingredient. This compound is characterized by its low molecular weight and its ability to enhance the production of erythropoietin (EPO) and hemoglobin. Specifically, the tetrahydroquinoline compound is represented by a general formula, where various groups and atoms are classified to optimize its efficacy.

Another groundbreaking patent involves a spiroindoline compound that acts as a glucokinase activator in the liver and pancreatic β-cells. This compound is designed to aid in the prevention and treatment of diseases related to hyperglycemia, including diabetes, showcasing Ishiwata's commitment to addressing pressing health issues through his inventions.

Career Highlights

Hiroyuki Ishiwata is currently employed at Kowa Company Limited, a distinguished name in the pharmaceutical industry. His work has not only contributed to the company’s innovation portfolio but has also placed him at the forefront of research in therapeutic agents. Through his inventions, he has significantly impacted the pharmaceutical landscape, emphasizing the importance of developing new treatments.

Collaborations

Throughout his career, Ishiwata has collaborated with noteworthy colleagues, including Mototsugu Kabeya and Seiichi Sato. These partnerships have allowed for the pooling of knowledge and expertise, further driving innovation in their mutual endeavors within Kowa Company Limited.

Conclusion

Hiroyuki Ishiwata stands out as an influential inventor in the pharmaceutical sector, with a remarkable catalogue of patents aimed at advancing health care solutions. His contributions, particularly in the development of compounds for treating conditions such as anemia and diabetes, reflect his dedication to innovation. As he continues his work at Kowa Company Limited, the impact of his inventions is likely to grow, reinforcing his position as a key figure in the field of pharmaceutical research.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…